As our goal is to identify pharmacologic approach to treat these cancer cells, we next used a variety of inhibitors targeting enzymes within these pathways, including several inhibitors of CRISPR screen dropout hits: DHFR, IMPDH, and GART (Fig. 3A), although it is important to note that these inhibitors may have additional targets. The gene discussed is DHFR; the disease is cancer.